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Betalactam resistance in Gram-negative 
bacteria 
[p12141 Extended Spectrum p-lactamases (ESBs) from 
Gram Negative Bacilli Isolated from 
Srinagarind Hospital, Thailand 
A. Lulitanond ' , W Kaewkas *, K. Kitcharoen I .  'Faculty of 
Associated Medical Sciences, Khon Kaen University, Khon Kaen 40002, 
Thailand, 2Faculty $Medicine, Khon Kaen University, Khon Kaen 
40002, Thailand 
Objectives: To study the prevalence of ESBs in certain genera of 
gram negative bacteria which are commonly isolated fivm patients 
of Srinagarind Hospital in northeast of Thailand, and determine 
the minimum inhibitory concentration (MIC) of cephalothin (CP), 
cefotaxjme (CTX), cetazidime (CAZ), ceftriaxone (CRO) and cef- 
operazone (CFP). 
Methods: Two hundreds strain of bacteria in family Enterobacten'- 
aceue and one hundred strain of bacteria in family Pseudomonadareae 
isolated fivm clinical specimens were studed. The test for ESBs was 
done by double disk a s i o n  procedure. The MC was studied by 
standard agar dilution method with Exherichia coli ATCC 25922 and 
Pseudomom aeruginosa ATCC 27853 as the control. 
Results: The results showed that 52 from 200 strains of Enter- 
obacteriaceae and 28 fivm 100 strains of Pseudomonadaceae produced 
ESBs (26% and 28% respectively). 63 of 80 ESBs producing strains 
have the MIC of CP CTX, CAZ, CRO and CFP above the cut 
off point (>8 ug/ml) and 17 strains have the MIC lower than the 
cut off point. The ESBs non producing strains have the MIC dis- 
tributed fivm 0.5 u g / d  to 64 u g / d  with the majority of strains 
were susceptible. 
Conclusions: About 26 to 28 percents of common gram nega- 
tive bacteria from clinical specimens were ESBs positive. About 78 
percents of the ESBs producing strains resist to the antibiotics stud- 
ied. 
I PI 21 51 Detection of the Extended-Spectnrm 
Beta-Lactamase (ESBL) Producing Klebsiella 
Pneumoniae Clinical Isolates 
H. Dimopoulou, E.D. Platsouka, S. Constantoulaki, 0. Paniara. 
Evangelismos General Hospital, Athem, Greece 
Objectives: Extended spectrum beta-lactamases are sometimes d&- 
ficult to detect by routine tests. We used E test strips to detect them 
and isoelectrofocusing analysis to idenafy their production. 
Methods: We selected 20 unrelated suspected ESBL-producing 
isolates of Klebsiella pneumoniae that were susceptible (S) or inter- 
mediate (I) to cefoxitin and resistant (R) to one or more of the 
following: ceftazidime (Caz), cefotaxime (CIX) and azmeonam (Am) 
and tested by E test ESBL strip. This strip (AB Biodisk, Solna, Swe- 
den) has two c e h d i m e  gradients on opposite ends of the strip, 
with clavulanic acid added to one of the gradients. An MIC ratio 
of Caz/Caz + clavulanic acid (CazCl) z16  is claimed to indicate 
the presence of an ESBL. The method was also tested with known 
ESBL strain. 
Results. The E test ESBL strip results showed that 19/20 of 
the isolates to be ESBL-producers with MIC ratios of z16  for 
Caz/CazCl. B-lactamases with pls 8.2 and 7.6 were found by iso- 
electric focusing in the tested isolates. 
Conciusions: E test ESBL strip appears to be a generally reliable, 
less subjective in the interpretation than the double disk a s i o n  test 
and technically simple method for the identification and/or confir- 
mation of ESBLs. 
I PI21 6 I Antibiotic Resistance and p-Lactamase 
production by Salmonella and Shigella Isolated 
in Tripoli-Libya 
S.S. Abeid, M.A. Daw, K.S. Ghenghesh. Medical Minobiology Dept, 
Faculty ofMedicine, Tripoli, Libya 
Objectives: To provide rehble information about the antibiotic 
susceptibility of Salmonella and Shigella species isolated in Tripoli, 
Libya and about their ability to produce B-lactamase. 
Methods: Included in this study 22 Salmonella and 11 ShigeZla iso- 
lated fivm the stool of children with or without diarrhoea aged less 
than 3 years. B-lactamase was detected by the iodometric method 
and antibiotic sensitivity by the dtsc &ion and method. 
Results: Of the 22 Salmonella and 12 Shigella tested, 8 (36%) and 
4 (33%) produced B-lactamase, 11 (50%) and 4 (36%) were resistant 
to ampicillin, 11 (50%) and 3 (27%) to chloramphenicol, 9 (41%) 
and 0 (0.0%) to gentamicin, 10 (45%) and 1 (8%) to kanamycin, 
4 (18%) and 10 (91%) to tetracycline and 10 (45%) and 7 (64%) 
to himethoprim-sulphamethoxazole. AU isolates were susceptible to 
ceftriaxone, ciproflaxacin, nalidixic acid and polymyxin B. 
Conclusions: Due to the high rates of resistance to the com- 
monly used antibiotics and production of B-lactamases by Salmonella 
and Shigella isolated in Tripoli, other drugs as ciprofoxacin should be 
considered as drugs of choice for the treatment of infections caused 
by these organisms. 
F] Cloning and Nucleotide Sequence Analysis of a 
M. Navia, J. Ruiz, C. Casals, M.T. Jimenez de Anta, J. Vila. 
Department ofMicrobiology, Hospital Clinic, School $Medicine, U of 
Barcelona, Spain 
Objective: To clone and analyse the nucleotide sequence of a gene 
&om A. baumannii c o d q  an OXA type B-lactamase. 
Methods: Isoelecaicfocusing was performed on a dirucal st ra in  
of A. baumannii which showed resistance to all B-lactam antibi- 
otics. PCR was carried out with integmn specific primers and the 
amplification product cloned into a pCRII vector. The clone was 
progressively sequenced. Susceptibdity testing was performed by the 
agar dilution method in accordance with the NCCLS guidelines. 
Results: A novel derived B-lactamase (OXA type) was found in 
an integron in A. baumannii which also contained an aadB gene. 
The isoelectric point was 7.0 and its nucleotide sequence diEered 
fivm that of OXA 3 in 4 bp. However, 2 of these 4 changes were 
silent. The other two mutations generated a substitution of Phe 59 
to Leu and Ile 217 to Met. The latter change has also been observed 
between OXA 2 and its derivative OXA 15. The amino acid se- 
quence homology between this OXA and OXA 3 was of 99.27%. 
This erqhne confers resistance to cephalotin, ticarcjllin, piperadm 
and ampicillin. Biochemical characterization of the B-lactunase is 
currently in progress. 
Conclusions: A new OXA type B-lactamase has been found. 
It is the first of its class to be described in A. baumannii and the 
first OXA 3 derivative found. Therefore, this new enzyme could be 
called OXA 19. 
Gene Coding an OXA TVpe p-lactamase 
Ip12181 Detection of Extended Spectrum p-lactamases 
in Clinical Isolates of Enterobacterspp. in Italy 
L. F'agani ' , R. Mighavacca ', E Luuaro ', R. Daturi I ,  V C a d 0  ', 
M.G. Ferrari I ,  C. Matti ', E Brisdelli ', G. Lombardi '. 'Lrt. Micro- 
biologia Univ Pauia, 'Osp. di Varese, 'Dip. STBB l'Aquila, Ztdy 
Objectives: E .  cloncae and E .  a e r o g m  are ihquently isolated fivm 
301 Betalactam resistance in Gram-negative bacteria 
patients in ICUs, climcal and surgical wards in our geographical area 
and the recovery of s t r a i n s  resistant to extended spectrum B-lactzms 
is increasingly fkquent. Derepression or stable derepression of AmpC 
B-lactamase represents the widely reported mechanism responsible 
for resistance to newer generation cephalosporins. ESBLs are rarely 
detected in Enterobacter spp. We assessed whether these enzymes rep- 
resent a significant cause of resistance in this genus. 
Methods. Enterobacter spp. strains were collected h m  two differ- 
ent hospitals in Northern Italy over two years. There is currently no 
reliable method designed for detection of ESBLs in isolates of Enter- 
obacteriaceae other than E .  coli and Kiebsiella spp.; since the cefepime 
retains reasonable activity against derepressed enterobacteria but is la- 
bile to hydrolysis by ESBLs we suspected the ESBL production when 
the isolates showed resistance or reduced susceptibility to cefepime. 
The double disk test was performed using amoxicillin-clavulanate 
and ceftaadime, cefotaxime, cefepime, aztreonam disks placed 30-22 
mm centre to centre. Production of chromosomal and plasmid me- 
diated j3-lactamases was also studied in crude cellular extracts. The 
enzymes extracted h m  clinical isolates and related transconjugants 
were characterized by biochemical and molecular methods. 
Results: All the strains showing an enhancement of the zone 
of lnhibition of cefepime by clavulanate resulted to be producing 
"EM or S H V  derivative B-lactamases plasmid mediated in addition 
to AmpC B-lactamase. 
Conclusions: In our geographical area the interplay of AmpC 
and TEM or S H V  derivative p-lactamases may account for enhanced 
resistance to B-lactams. 
-1 Betalactamase of frevotella Species: 
Characterization and Substrate Profile 
A. Sedallian, N. Allart, S. Bland. Laboratoire de Bactm'ologie CH 
Annecy, France 
Prevotella are increasingly encountered in clinical specimen. We 
report a study of 306 strains isolated h m  clinical specimens in 
our laboratory. 157 strains were betalactamase secretor. The MICs 
of Amoxicillin, Amoxicillin more clavulanic acid, Piperacillin, Ce- 
furoxim, Cefotaxim, Cefotaxim more sulbactam and Cefoxitin were 
determined by agar dilution method according to NCCLS recom- 
mendation. 
Nine betalactamase positive strains were examined for enzymatic 
substrat profile. The cultures were performed on agar. The cells 
were harvested after 40 to 60 hr of incubation. The enzyme, were 
extracted by sonication. The cephalosorinase activity, of the crude 
extracts was measured by specaophotometric method with nitro- 
cephin and the ratio Vm/Km was determined. The betalactamase 
positive strains have relatively hgh MICs of Ampicillin, Piperadme 
Cefuroxim and Cefotaxim. All enzymes hydrolysed CepMotin, Ce- 
furoxim and Cefotaxim, but weakly and slowly Ampidm. None 
of there enzymes hyddysed Cefoxitin. Addition of clavulanate or 
sulbactam led to a sigtllfcant decrease of the MICs. 
Specific activity of extract appeared correlated with MICs to 
Ampicilline and Cefumxim. 
I PI 220 I Hydrolysis of Cephalosporins and 
Carbapenems by Sphingobacterium 
mukivorum Strains 
J. Blahovi ', V KrZmiry ', K. Kubo&ovi2. 'Institute cfReventive and 
Clinical Medicine, Bratislava, Slovak Republic, 'Dtrer's Hospital, 
Bratislava, Slovak Republic 
Objectives: Sphingobactm'um (Flavobacterium) multiwrum is a rare 
causal agent of nosocomial infections in hospitalised patients. 
Methods: Three S. multivorum s t r a i n s  isolated in DCrer's Hospital 
in Bratislava were identified using the SCEPTOR (Becton Dick- 
inson). Antimicrobial susceptibility testing was performed by disc 
&sion test. The relative rate of hydrolysis (Vmax) of antibiotics 
was estimated by the macro-iodometric method. ESBLs profile of 
strains was performed using double disc d&sion test. 
Results: S. multivorum No. 283 and 137 (resistant to cephalo- 
tine, cefotaxime, ceftandime, imipenem, meropenem and aztre- 
onam), unlike the No. 280 (resistant to cephalotine, imipenem amd 
meropenem), produced ESBLs. Moreover, mutant colonies of the 
strain No. 137, resistant to clavulanate inhibition of the ESBL, ap- 
peared in the zones of inhibited growth around discs of cefotaxime 
and ceftandime. The hydrolysis of cefotaxime and ceftandime was 
inhibited by clavulanate in the sonicates of strains No. 283 and 137. 
Hydrolysis of imipenem was inhibited by EDTA in both strains. The 
mutant colonies of the strain No. 137 were inhibited by EDTA, but 
not by clavulanate. 
Conclusions: From results it might be concluded, that S. multivo- 
rum strains No. 283 and 137 produce metallo-B-lactamase conferring 
them resistance to carbapenems and, ESBLs hydrolysing cefotaxime 
and ceftazidime inhibited by clavulanate. Strain No. 137 produces 
clavulanate-resistant variant(s) of ESBL(s) too. 
I PI221 1 Three New TEM p-lactamases Expressed by 
Ceftazidime-Resistant K. pneumoniae and f. 
coli Isolates from Polish Hospitals 
M. Gniadkowski ', I. Schneider ', R. Jungwrth ', W Hryniewicz ', 
A. Bauernfeind'. 'Sera G Vm'nes Central Research Laboratory, 
Warsow, Poland, 'Max von Pettenkofer-lnstitut, Munich, Germany 
The objective of the study was to identify extended-spectrum 
B-lactamases produced by a group of Enterobocteriaceae isolates from 
Poland. 11 K. pneumoniae and 1 E .  coli isolates were collected 
&om 3 hospitals: in L6&, Rzeszdw and Warsaw, at the begin- 
ning of 1995. All of them were uniformly resistant to ceftazidime. 
The RAPD analysis was used to reveal epidemiological relation- 
ships among K .  pneumoniue isolates. Isolates were subjected to cef- 
tazidime-resistance-transfer experiment. B-lactamases expressed by 
both wdd type and transconjugants st ra ins  were visualised by IEF. 
The ceftazidimase activity was assigned to a given IEF band by the 
bioassay approach. Plasmid DNAs were purified h m  transconju- 
gants cells and used as templates in PCR reactions with &ITEM or 
blaSHV specific primers. Resulting PCR products were sequenced. 
Cefcazidimases with a pl of 6.0 were detected in extracts of one 
K.  pneumoniae and the E .  coli isolates from L6&, and 4 K. pneumo- 
niae isolates h m  the dona  outbreak in Rzesz6w. These enzymes 
were expressed by transconjugants. Sequence analysis has revealed 3 
different but closely related TEM B-lactamase sequences: TEM-47 
(G238S:E240K:T265M), TEM-48 (L21FG238S:E240KT265M) 
and TEM-49 (L21FG238S:E240KT265M G268S). The remainder 
of 6 K. pneumoniae isolates taken to the study were found to produce 
the SHV-5 ES-B-lactamase. The group of new TEM variants might 
represent a part of a common branch within the evolutionary tree of 
TEM B-lactamases. 
1 PI 222 I ESBL-Producing Strains in a Belgian University 
Hospital 
D. Pierard, E. Nulens, G. Muyldermans, S. De Bock, 
K. Emmerechts, A. De Backer, S. Lauwers. A Z - W B  Brussels, 
Belgium 
Objectives: 1" To evaluate the role of ESBL (extended spectrum 
B-lactamase) production as mechanism of resistance to third gener- 
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ation cephalosporins at the AZ-VUB. 2’ To determine which de- 
tection test can be used routinely. 3” To investigate the genetic rela- 
tionship between difZerent ESBL positive strains of the same species. 
Methods: Three synergism tests, the double b k  test (DD), the 
comparison of cksk a s i o n  zones on MH f davulanate (MC) 
and the Rosco test (RC) combining amoxycilldclavulanate and 
cephalosporin disks were applied to 240 selected cknical isolates (132 
Mebsiella spp., 103 Enterobacter spp. and 5 E .  colr). The reference for 
an ESBL positive isolate was a MIC ratio f davulanate of 216 for 
at least one of the following: cefotaxjme, ceftliaxone, ceftazidime, 
cefepime and aztreonam. ESBL-producers were typed by randomly 
amplified DNA polymorphism (RAPD). 
Results: 107 MebsielZa spp. (59 K. oxyfoca and 48 K. pneumoniae), 
4 E .  cdi, 2 E .  cloacae and 1 E .  sakazakii had at least one MIC ra- 
tio 216. This corresponds to 15.4% of all K. pneumoniae isolates 
and 31.5% of all K. oxytoca (the latter being a mixed population 
of ESBL-producers and K1-hyperproducers accordmg to their cef- 
tazidime susceptibility). The MC method had the best sensitivity, 
followed by DD, while RT was not useful. For practical reasons, DD 
has to be preferred for routine use. The ESBL+ K. pneumoniae could 
be divided in 6 RAPD groups and K. oxyfoca in 7 but in each species, 
a predominant group comprised 80% and 60% of strains respectively. 
Conclusions: In contrast with other hospitals, in the AZ-VUB, 
ESBL production is hquent in K. oxyfoca as well as in K. pneumoniae 
strains. DD seems to be best adapted for routine use. Although 
several RAPD types were present, the predominance of one type 
in each species suggests nosocomial transmission. 
1 PI 223 I Characterization of an Extended-Spectrum 
p-lactamase Isolated from a Nosocomial E. coli 
Strain 
L.V. Peke ’, J.-C. Perez-Diaz ’, J.C.E Sousa ’, E Baquero ’. ‘Fac. de 
Farmricia, Univ. do Porfo, Portugal, ’Hosp. Ramdn y Cajal, Madrid, 
Spain 
Objectives: Identification of the mechanisms of resistance to 
b-lactams of an multiresistant nosocomial E .  coli strain with a 
SHV-type behavior. 
Methods: Identification and susceptibility testing were performed 
by API 32GN (BioMkrieux) and Kirby-Bauer disk a s i o n  tests. 
The MICs were determined by E-tests (AB Biodisk) performed on 
Mueller-Hinton agar plates (BioMirieux). IEF was performed in 
precast polyacrylamide gels (PH range, 3 to 9) by using a Pharmacia 
(Uppsala) PhastSystem apparatus. Nitrocefin (GlaxoWelcome) was 
used for detection of B-lactamase activity. Recombinant DNA tech- 
niques were performed as described by Sambrook et al. (1989). Nu- 
cleotide sequence was determined by the dideoxynucleotiide chain 
termination method by using T7 DNA polymerase (Pharmacia) and 
bla SHV-5 specific primers. 
Results: E .  coli FF750 with a SHV-type behavior, which is char- 
acterized by high resistance to ceftazidime, aztreonam and cefo- 
h e ,  produce two f?-lactamases of isoelecaic point 5.4 and 8.2 
coded by Werent conjugative plasmids. By sequencing the pl 8.2 
b-lactamase gene we found the typical mutations of SHV-5 enzyme: 
238 &cine by serine and 240 glutamic acid by lisine. 
The plasmids encoding SHV-5 and TEM-1 contains sequences 
encodmg the aminoglycosides inactivating enzymes AAC (3)-Va, 
APH (3’)-Ia and AAC (6’)-Ib 
Conclusions: After this first report of an SHV-5 producing E. 
coli s t r a i n  isolated at a Portuguese hospital, epidemiology studies will 
be required for controlling its spread. 
I PI 224 I Survey of Extended Spectturn p-lactamases 
(ESPL) in Entembacteriaceae Clinical lisolates 
from North Italian Hospital 
L. Pa@ ’ , l? Micheletti ’ , R. Daturi ’, R. M&avacca 
E. Giacobone’. ‘Ist. Microbiol. Uniu. Pauia, Pavia, Ifafy, ’Lab. 
Microbial. I R C C S  S. Matfeo, Pauia, Italy 
Objectives: ESPLs are widely spread enzymes. The extent to which 
this happens varies with time, with the hospital or unit type and with 
the usage of newer cephalosporins. So we have carried out a survey 
of ESbLs in enterobacteria from our hospital over one year period 
to evaluate their sigdicance among the pathogen isolates in various 
wards. 
Methods: Many ESbL producing isolates are not resistant to 
newer cephalosporins or aztreonam in routine susceptibility tests, 
t h i s  is disturbing since ESbLs have been associated with cknical fail- 
ures even when only low-level resistance was apparent in vitro. So 
we have studied the ESPL production in 620 enterobacteria from 
patients in ICUs, &nical and surgical wards, apart h m  the expres- 
sion of resistance, by GNS-LM card (VITEK System, bioMkrieux). 
The double disk test was also performed. As quality controls we have 
chosen strains of E .  coli producing ESSLs group 2be and non-ESbLs. 
Results: ESPLs were detected in 15% of isolates with incidence 
values ranging from 29.5% in S. mamcenr to 11.2% in I! mirabilis. 
(13.3% E .  coli, 12.3% K. pneumoniae). The data obtained revealed 
that S. marretcens and Enferobacter spp. are emerging as ESSL produc- 
ers at our hospital. Moreover up to 50% of ESbL producing E .  coli 
resulted to be susceptible to ceftazidime and aztreonam with phar- 
macological breakpoints. During the survey was also detected the 
epidemic spread of TEM-8 like producing K. pneumoniae at an ICU. 
Conclusions: Our results confirmed the need of a constant mon- 
itoring of ESSLs in Enterobacfm’aceae to prevent and control their 
dissemination. 
I PI225 1 Emergence of an lmipenem Resistant 
E MacKenzie, A. Williams, K. Forbes, 1.M. Gould. Depf. of 
MicrobioZoa, Royal Infirmary, Aberdeen, Scotland 
The North-East of Scotland is currently experiencing an outbreak of 
multiply-resistant K. pneumoniae (MRK), capsular type K2 with ex- 
tended spectrum B-lactamase activity, sensitive only to carbapenems, 
armkacin and colistin. During the outbreak a patient with leukaemia 
was found to have septicaemia caused by MRK (strain A) and was 
treated with imipenem for 10 days. Two days after the completion of 
therapy an imipenem resistant (IMP-R) isolate (strain B) believed be 
the MRK was recovered from a stool sample. Seventeen days after 
this an imipenem sensitive variant was recovered from a further stool 
sample and the IMP-R variant was never isolated from this patient 
again. Careful epidemiologic investigations have failed to detect any 
environmental or patient spread of the imipenem resistant organ- 
ism. The following MIC d u e s  (pg/ml) were determined by the 
NCCLS microdilution method. 
Klebsiella pneumoniae 
~ 
Stmn mpencm mcropcnem ccfocctan ccfotlnmc (a) cm/CLv acid 
A 0.06 0.016 0.25 8 0.125 
B 4  8 >32 >I024 1024 
MIC values of 0.5 and >32 p g / d  for imipenem were obtained 
with strains A and B respectively using the E-test method. The iso- 
lates were verified as K. pneumonie by two methods. The non-motile 
organisms gave an API 20E profile of 5215773. 16s ribotyping us- 
ing dye deoxyterminator sequencing also confirmed the identifi- 
cation. Having sequenced 820 nucleotides of the gene, strain B 
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showed 100% slrmlarity with a randomly selected outbreak MRK 
and >99% similarity with K. pneumoniae NCTC 9633. This is in the 
first IMP-R organism that we are aware has been confirmed as K. 
pneumoniae by molecular methods. The mechanisms of resistance is 
being investigated. 
1 PI226 I Cefepime and Stepwise Selection of 
Resistance 
H. Carsenti-Etesse, EM. Roger, A. Thabaut, E Dellamonica. .Archet 
Hospital, Nice, France 
Objectives: comparative selection of resistance to cefepime (FEP), 
ce@irorne (CPO), ceftazidune (CAZ), cefotaxime (CTX) and 
h p e n e m  (IMP) 
Methods: selection was performed on 9 Pseudomom amginosa (5 
wild phenotype), 5 Enterobacter cloacae, 4 Smatia marcescens s t r a i n s  by 
daily transfer in submhibitory concentrations (subMICs) of antibi- 
otics using a spiral inoculator. Bacterd inoculum was 10 cfu/ml 
and spontaneous mutants were often present with CTX, CAZ in the 
original population at 4xMIC. They appeared during transfers more 
rapidly with CPO than with CPM or IMP. Only colonies growing 
in subMICs were taken for serial passages. 
Results: expressed as mean number passages necessary with each 
selecting antibiotic to reach intermediate (I) or resistance level (R) 
(number of shains reaching this level out of number tested) 
CTX CAZ CPO FEP IMP 
E. ~ l ~ o i u n e  
1 level 8 (415) 10.5 (515) 10 (315) 28.8 (415) 31 (415) 
Rlevel 11.5 (415) 17.2 (4/5) 14 (315) 25.5 (215) >30 (015) 
I level 3 (414) 7 (515) 6 (414) 11.8 (515) 15.8 (515) 
Rlevel 3.5 (4/4) 18 (415) 15 (414) 30 (415) 27.3 (315) 
I level 13 (313) 9.7 (3/4) 18 (314) 14.7 (314) 30 (114) 
R level 16.3 (3/3) 20.5 (2/4) 31 (213) 19 (214) 31 (114) 
Pr. emginow ( A d  phenotype rminr) 
s. mr?mmm 
Conclusions: Rate of selection was lower with IMP and FEI? 
Mutants selected with CTX, CAZ remained susceptible to I W ,  FEP 
and CPO indeed those selected with FEP and CPO were more often 
cross R to all cephalosporins probably due to higher cephalospori- 
nase production related to slower development of resistance. 
1 PI2271 Varied Potentials of P-Lactam Antibiotics in 
the Selection of Resistance in Clinical 
Enterobacter cloacae Isolates 
E.WC. Chan', R.C. Li', J.M. Ling', A.E Cheng', J.J. Schentag*. 
' B e  Chinese University OfHong Kong, Hong Kong, zState University .f 
New York at Buflalo, USA 
Objectives: To test the abllity of eight commonly-used and newer 
p-lactams to select resistant Enterobacter cloacae isolates in the search 
for those with a high antimicrobial activity and a low resistance 
induction potential for antimicrobial chemotherapy. 
Methods: Nine standard and &cal E cloacne isolates were sub- 
cultured daily in test antibiotics at doubling concentrations from 
0.125 x MIC to 12 x MIC. Resistance development was moni- 
tored by a disk dif€usion test throughout the passages. 
Results: All isolates managed to grow in the presence of 12 x 
MIC of all cephalosporins tested and meropenem wMe imipenem 
eradicated all at 8 x MIC. Ceftaudime, ceftriaxone and cephaman- 
dole selected resistance at a faster rate than cefopenzone while ce- 
fepime, cefpirome, imipenem and meropenem showed relatively low 
resistance-selection potential. Although cross-resistance was a com- 
mon phenomenon amongst the resistant mutants, cross-resistance to 
cefiuoxime and cephamandole developed most readily upon selec- 
tion by other antibiotics but rarely to the carbapenems. The resis- 
tance phenotypes of most selected s t r a i n s  remained stable upon serial 
passages in antibiotic-fke medium for 10 days. 
Conclusions: Second and third generation cephalosporins se- 
lected resistance much faster than fourth generation cephalosporins 
and carbapenems. Resistant mutants exhibited cross-resistance to 
cephalosporins but not to carbapenems. 
(p12281 Role of the Outer Membrane Proteins in the 
Permeability of Beta-Lactams 
2. Pragai, E. Nagy. Dept. .f Clinical Microbiology, Albert 
Szent-GyBrgyi Medical University, Szeged, Hungary 
Objectives: To evaluate the role of the outer membrane proteins 
(OMP) in the resistance to different beta-lactams and beta-lactam 
plus idubitor combinations in Klebsiella pneumoniae isolates. 
Methods: Two Klebsiella pneumoniae s t r a i n s  were investigated, 
one of them produced an SHV-3 extended-spectrum beta-lactamase 
while the other was non ESBL producer. Strains were idenafied 
by ATB (BioMerieux). MICs of antimicrobial agents were deter- 
mined by microbroth dilution method. Cefoxitin-resistant mutants 
could easily be selected on cefoxitin containing medium and outer 
membrane proteins of the mutans were prepared and analysed on 
SDS-PAGE. Conjugation assay was carried out with E .  coli J53-2. 
Beta-lactamase activity was measured by using nitrocefin. 
Results: Correlation has been found between the loss 
of 35-kDa and 36-kDa proteins and decreased susceptibil- 
ity to beta-lactam and beta-lactamase inhibitor combinations, 
and resistance to 7-a-methoxy-beta-lactams, aztreonam and ex- 
tended-spectrum cephalosporins in the SHV-3 producing strain. 
The OMP alteration alone in strain 53,283 proved to be insuf€i- 
cient to cause resistance to extended-spectrum cephalosporins and 
beta-lactam plus inhibitor combinations, with the exception of ce- 
foxitin and latamoxef. Mutants obtained 6urn 46,655, showed ele- 
vated level of MICs to quinolons. 
I PI 229 1 ESBL Producing Escherichia coli in Neonatal 
ICU Patients 
V. Tripkovit, B. Rebrovit, S. Kalenif, V. Pleiko. Clinical Hospital 
Centre Zagreb, Zagreb, Croatia 
Objectives: To determine if Escherichia coli (E. coli) strains isolated 
from clinical specimens wbch were resistant to ceftazidime in disc 
d&sion test, were ESBLs producers. 
Methods: Strains isolated &om wines of 8 patients and blood 
cultures of 2 patients in neonad intensive care unit (NICU), were 
identified as E. coli with BBL Crystal E/NF ID Becton Dickinson 
and W I D  ID 32 E BioMeriew; disc diffusion test was peformed 
with Kirby-Bauer procedure for amoxicillin, amoficilin-clavulanic 
acid, cefotaxime, cefoperazone, cehaxone, ceftaudune, gentamicin 
and amikacin; than MICs were determined with agar dilution tech- 
nique for amoxicillin, amoxicilin-cla&c acid, cefotaxime, cef- 
operazone, cefiriaxone, cefcazidime, and "double-disc =sion test" 
with amoxicillin-davulanic acid (20/10 pg) and ceftazidime (30 pg) 
discs. QC strain was E. coli ATCC 25,922. 
Results: MICs of all strains for amoxicilin were >lo24 pg/ml, 
for cefotaxime, cefoperozone, ceftriaxone and ceftazidime from 32 
to > 1024 pg/nd, and for amoxidm-davulanic acid from < 1 to 256 
pg/ml. Double disc &sion test showed in all the strains synergistic 
effect of cehzidime and clavulanic acid. AU strains were resistant to 
aminoglycosides. 
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Conclusion: ESBL-producing aminoglycosides resistant E. coli 
s t r a i n s  isolated h m  clinical specimens in our NICU are first such 
strains proven in Croatia and should be of great concern in NICU 
patients. 
Candida i nfedio ns 
ml Candidaemia: A Cause or Effect of Staph. 
Septicaem ia ! 
C. W a d ,  A. Sharma. Sir Ganga Ram Hospital, New Delhi, India 
Objectives: Staph. aureus and Candida septicaemia cases were pur- 
sued to evaluate their causal relationship to each other. 
Methods: 1255 blood cultures were studied, using BacT/Alert 
(Organon-Teknika) Blood Culture system. Isolation of Staph. aureus 
(SA), Coagulase Negative Staph. (CNS), Candida sp. (C) and muc- 
ture of organisms SA+C or C+SA were evaluated as per the above 
objective. 
Results. 
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CNS cases had or developed Candidaemia. 10113, SA+C cases 
started with Staph. aureus (6) or Candida (4) septicaemia and pro- 
gressed to SA+C or C+SA on follow up. 2/36 Candida cases, had 
mixed septicaemia other than Staph. aureus, like E. coli, Enterobder 
sp, etc. whereas 13/36 cases developed SA+C septicaemia. 
Conclusions: The above suggests a cause and effect relationship 
of Staph. aureus and Candida sp. infections probably by way of pro- 
ducing mutually beneficial chemotactic or p w t h  factors that need 
furcher study. 
Candida Sepsis in Patients with HIV Infection 
M. Tumbarello, E. Tacconelli, G. Morace, R. Cauda. Departments 4 
Infem.ous Diseaes and Microbioloa, Rome, Italy 
Objective: to evaluate the risk and prognostic factors of the sepsis 
due to Werent species (spp.) of Candida in H N  infected patients 
admitted at OUT ward h m  1989 to 1996. 
Methods: a case control study was performed. A control p u p  of 
64 patients with AIDS and without sepsis was included in the study 
Results: we observed 32 H N  infected patients (the large major- 
ity of them were males, intravenous drug abusers and with AIDS) 
with Candida spp. sepsis. The isolated strains were C. albicans in 18 
episodes. (eps., 56%), C. tropicalis in 4 eps. (13%). C. glabrata in 3 
eps. (9%)). C. parapsilosis, C. h s d  and C. guillimnondii in 2 eps (6%), 
respectively and C. zeylanoides in 1 eps. Univariate analysis of predis- 
posing factors indicated that the low CD4+ T cell level t100/mmc 
(P = 0.02), the CVC usage (P = 0.02) and the neutropenia (neu- 
tmphils count <lOOO/mmc) (P = 0.04) were risk factors associated 
with the development of Candida sepsis. The response to therapy 
was favourable in 22 eps. (69%); death occurred in 10 eps. (31%). 
while a recurrence occurred in only 1 eps. The outcome of sepsis 
was influenced by the low number of CD4+ T cell (P = 0.01) and 
of neutmphils (P = 0.03). 
Conclusions: our data suggest that Candida sepsis is an important 
event in HIV-infected patients, especially under particular condi- 
tions (e.g. CVC usage, neutropenia and low CD4+ T cell level) and 
it requires a special attention h m  the physicians who must early 
recognise and treat this condition. 
w1 Candidemia: A Retrospective Study 
A. Garcia-Zabarte, M. Trevhio, C. Garcia-Kestra, M.D. Peiialver, 
A. Aguilera, B.J. Regueiro. Uniwnify Hospital Complu oJSanfiazo, 
Spain 
Objective: To evaluate, retrospectively, bloodstream episodes of 
Candida spp. along one year (1.995). 
Methods: Hemocultures were incubated in Bact Alert System. 
Positive samples were subcultured in Saboureaud agar (Biomerieux) 
and yeast isolates were identified by Vitek System (Biomerieux). C. 
parapsilopsis antdingal susceptibilities were assayed by E-test. 
Results: Total number of candidemias along 1.995 was twenty- 
five belonging to twentythree hospitalized patients. The yeast more 
ofienly isolated was C. parapsilopsis (52%) followed by C. albicans 
(32%). Other Cnndida species found were C. tropicalis, C. glabrata and 
C. lusitaniae. Fungemia by C. parapsilopsis was sigmficatively associ- 
ated to tumoral and pebtric patients (36% and 44%, respectively). 
We have not found any association between candidemia and age of 
patients. 
All C. parapsilopsis strains were sensitive to ketoconazole, flu- 
conazole, itmconazole, amphotericine B and flucitosine (MIC 90 
1 mcg/mL.). 
(1) G. parapsilopsis has just emerged as an important nosocomial 
(2) The prevalent yeast isolated firom fungal blood infections is C. 
(3) C. parapsilopsis strains isolated h m  hospitalzed patients are sen- 
Conclusions: 
pathogen in our hospital. 
parapsilopsis. 
sitive to the main systemic antifungal drugs. 
Candida spp. an important Pathogens in 
Nosocomial infections 
A. Samet, E. Czarniak. Deparfment 4 Clinical Bodm'olo~,  State 
Clinical Hospital W 1 in Gdansk, Poland 
Objectives: The aim of this study was to determine the influence of 
intensified antimicrobial therapy and intensive care measures on the 
incidence of Candida spp. isolated h m  different clinical specimens. 
Methods: We analysed 77 872 records of our dinscal mimbiol- 
ogy laboratory firom 1.1.1994 to 31.12.1995. 
Results: The incidence of Candida spp. in dinscal materials was 
higher about 36% in 1995 than 1994. Candida spp was the third 
most common organism recovered 6um the blood cultures in 1995, 
much increase comparing 1994 (the seventh place). Gandida albicans 
is still the predominant pathogen among the genus Gandida in our 
hospital. Two hospital units: ICU and Haematological Department 
had the most sigruficant increase in the incidence of Candih spp. 
Interestingly, in 1995 we observed a high increase in the incidence 
of Candida (Torulopsis) glabrata recovered 6um Merent dinical spec- 
imens. Candida (Torulopsis) glabrata represented 9% of all yeast isolates 
therefore special atcention should be paid to the treatment of fun- 
gal infections in our hospital (this species is kequently resistant to 
fluconazol). T h  increase is probably associated with a broad use of 
fluconazol in prophylaxis and empirical treatment of fungal mfec- 
tions in OUI hospital. 
